Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Epigenomics AG 

18.11.2015 18:30

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Voting Rights: Release of Voting Rights Notifications (§ 21 para. 1 German
Securities Trading Act - 'WpHG') in Accordance with § 26 para. 1 WpHG with
the Aim of an Europe-wide Distribution

Issuer:
Epigenomics AG
- ISIN DE000A11QW50 -
Geneststr. 5
10829 Berlin
Germany

Voting Rights Notifications:

1. On 17 November 2015, James E. Flynn, USA, notified Epigenomics AG of
voting rights in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as
follows:

On 11 November 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of James E. Flynn in the voting
rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21
para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting
rights (522,791 voting rights) in Epigenomics AG.

All 2.89 per cent of the voting rights (522,791 voting rights) are
attributed to James E. Flynn pursuant to sec. 22 para. 1 sent. 1 no. 1 WpHG
and pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG in connection with sec.
22 para. 1 sent. 2 WpHG.

2. Furthermore, on 17 November 2015, J.E. Flynn Capital, LLC, Wilmington,
Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics AG
pursuant to sec. 21 para. 1 WpHG as follows:

On 11 November 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of J.E. Flynn Capital, LLC in the
voting rights of Epigenomics AG fell below the 3 per cent threshold of sec.
21 para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the
voting rights (522,791 voting rights) in Epigenomics AG.

All 2.89 per cent of the voting rights (522,791 voting rights) are
attributed to J.E. Flynn Capital, LLC pursuant to sec. 22 para. 1 sent. 1
no. 1 WpHG.

3. Furthermore, on 17 November 2015, Deerfield Mgmt, L.P., Wilmington,
Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics AG
pursuant to sec. 21 para. 1 WpHG as follows:

On 11 November 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of Deerfield Mgmt, L.P. in the voting
rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21
para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting
rights (522,791 voting rights) in Epigenomics AG.

All 2.89 per cent of the voting rights (522,791 voting rights) are
attributed to Deerfield Mgmt, L.P. pursuant to sec. 22 para. 1 sent. 1 no.
1 WpHG.

4. Furthermore, on 17 November 2015, Deerfield Special Situations Fund,
L.P., Wilmington, Delaware, USA, notified Epigenomics AG of voting rights
in Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows:

On 11 November 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of Deerfield Special Situations Fund,
L.P. in the voting rights of Epigenomics AG fell below the 3 per cent
threshold of sec. 21 para. 1 WpHG and amounted, as at this date, to 2.89
per cent of the voting rights (522,791 voting rights) in Epigenomics AG.

5. Furthermore, on 17 November 2015, Flynn Management LLC, Wilmington,
Delaware, USA, notified Epigenomics AG of voting rights in Epigenomics AG
pursuant to sec. 21 para. 1 WpHG as follows:

On 11 November 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of Flynn Management LLC in the voting
rights of Epigenomics AG fell below the 3 per cent threshold of sec. 21
para. 1 WpHG and amounted, as at this date, to 2.89 per cent of the voting
rights (522,791 voting rights) in Epigenomics AG.

All 2.89 per cent of the voting rights (522,791 voting rights) are
attributed to Flynn Management LLC pursuant to sec. 22 para. 1 sent. 1 no.
6 WpHG in connection with sec. 22 para. 1 sent. 2 WpHG.

6. Furthermore, on 17 November 2015, Deerfield Management Company, L.P.,
Wilmington, Delaware, USA, notified Epigenomics AG of voting rights in
Epigenomics AG pursuant to sec. 21 para. 1 WpHG as follows:

On 11 November 2015, as a consequence of the disposal of shares to which
voting rights are attached, the share of Deerfield Management Company, L.P.
in the voting rights of Epigenomics AG fell below the 3 per cent threshold
of sec. 21 para. 1 WpHG and amounted, as at this date, to 2.89 per cent of
the voting rights (522,791 voting rights) in Epigenomics AG.

All 2.89 per cent of the voting rights (522,791 voting rights) are
attributed to Deerfield Management Company, L.P. pursuant to sec. 22 para.
1 sent. 1 no. 6 WpHG.

Date of release: 18 November 2015

Epigenomics AG
The Executive Board



18.11.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Epigenomics AG
              Geneststraße 5
              10829 Berlin
              Germany
Internet:     www.epigenomics.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------